Skip to main content
OpenTrials
Completed

NCT Number: NCT05939089

Cardiovascular Assessment of Pediatric Cancer Survivors

The goal of this observational study is to evaluate cardiac and vascular health status of pediatric cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Left Ventricular Dysfunction Cardiotoxicity Cardiovascular Diseases Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions Heart Diseases Heart Failure Pathologic Processes Pathological Conditions, Signs and Symptoms Radiation Injuries Ventricular Dysfunction Ventricular Dysfunction, Left Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Faculty of Medicine

Fatih, Istanbul, 34093, Turkey (Türkiye)

About this study

All pediatric cancer survivors were evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed cancer at pediatric age

Exclusion criteria

  • Having cancer after 18 years of age

Treatment and study plan

ECG, Echocardiography, cTnI, NT-ProBNP

Diagnostic Test

All pediatric cancer survivors are evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.

Primary outcomes

  1. Rate of LV Dysfunction

    Time frame: From the first visit at cardio-oncology division through study completion, an average of 2 years

    Echocardiographic evaluation of left ventricular functions

Sponsors and collaborators

Lead sponsor

Istanbul University

Other

Registry information

Official study title

Cardiovascular Assessment of Pediatric Cancer Survivors: Understanding Long-Term Effects and Risks

Acronym: CASPER

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jul 11, 2023
Registry last updated
Jul 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.